nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—CYP3A5—Sorafenib—thyroid cancer	0.0835	0.198	CbGbCtD
Clonidine—CYP1A2—Sorafenib—thyroid cancer	0.0622	0.147	CbGbCtD
Clonidine—ABCB1—Sorafenib—thyroid cancer	0.0544	0.129	CbGbCtD
Clonidine—CYP3A4—Vandetanib—thyroid cancer	0.054	0.128	CbGbCtD
Clonidine—CYP2D6—Sorafenib—thyroid cancer	0.0512	0.121	CbGbCtD
Clonidine—ABCB1—Doxorubicin—thyroid cancer	0.033	0.0782	CbGbCtD
Clonidine—CYP3A4—Sorafenib—thyroid cancer	0.0326	0.0772	CbGbCtD
Clonidine—CYP2D6—Doxorubicin—thyroid cancer	0.0311	0.0737	CbGbCtD
Clonidine—SLC22A4—larynx—thyroid cancer	0.0199	0.212	CbGeAlD
Clonidine—CYP3A4—Doxorubicin—thyroid cancer	0.0198	0.0469	CbGbCtD
Clonidine—SLC22A4—neck—thyroid cancer	0.00528	0.0563	CbGeAlD
Clonidine—NISCH—trachea—thyroid cancer	0.00481	0.0512	CbGeAlD
Clonidine—NISCH—thyroid gland—thyroid cancer	0.0038	0.0405	CbGeAlD
Clonidine—SLC22A3—saliva-secreting gland—thyroid cancer	0.00375	0.0399	CbGeAlD
Clonidine—SLC22A4—trachea—thyroid cancer	0.00318	0.0339	CbGeAlD
Clonidine—ADRA1B—head—thyroid cancer	0.00288	0.0307	CbGeAlD
Clonidine—ADRA1D—head—thyroid cancer	0.00281	0.03	CbGeAlD
Clonidine—SLC22A5—saliva-secreting gland—thyroid cancer	0.00273	0.029	CbGeAlD
Clonidine—SLC22A4—thyroid gland—thyroid cancer	0.00251	0.0268	CbGeAlD
Clonidine—NISCH—lymph node—thyroid cancer	0.00236	0.0252	CbGeAlD
Clonidine—SLC22A3—thyroid gland—thyroid cancer	0.00229	0.0244	CbGeAlD
Clonidine—ADRA2C—trachea—thyroid cancer	0.0022	0.0234	CbGeAlD
Clonidine—SLC22A1—head—thyroid cancer	0.00212	0.0226	CbGeAlD
Clonidine—SLC22A5—trachea—thyroid cancer	0.0021	0.0224	CbGeAlD
Clonidine—SLC22A3—head—thyroid cancer	0.00203	0.0216	CbGeAlD
Clonidine—Dyspnoea—Vandetanib—thyroid cancer	0.00189	0.00425	CcSEcCtD
Clonidine—Hyperaesthesia—Epirubicin—thyroid cancer	0.00189	0.00424	CcSEcCtD
Clonidine—CYP1A1—trachea—thyroid cancer	0.00188	0.02	CbGeAlD
Clonidine—Tinnitus—Sorafenib—thyroid cancer	0.00188	0.00422	CcSEcCtD
Clonidine—Cardiac disorder—Sorafenib—thyroid cancer	0.00187	0.0042	CcSEcCtD
Clonidine—Decreased appetite—Vandetanib—thyroid cancer	0.00184	0.00414	CcSEcCtD
Clonidine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00183	0.00412	CcSEcCtD
Clonidine—Fatigue—Vandetanib—thyroid cancer	0.00183	0.00411	CcSEcCtD
Clonidine—Angiopathy—Sorafenib—thyroid cancer	0.00183	0.00411	CcSEcCtD
Clonidine—Mediastinal disorder—Sorafenib—thyroid cancer	0.00181	0.00408	CcSEcCtD
Clonidine—Pain—Vandetanib—thyroid cancer	0.00181	0.00408	CcSEcCtD
Clonidine—Constipation—Vandetanib—thyroid cancer	0.00181	0.00408	CcSEcCtD
Clonidine—Arrhythmia—Sorafenib—thyroid cancer	0.0018	0.00404	CcSEcCtD
Clonidine—Alopecia—Sorafenib—thyroid cancer	0.00178	0.004	CcSEcCtD
Clonidine—Mental disorder—Sorafenib—thyroid cancer	0.00176	0.00397	CcSEcCtD
Clonidine—Skin ulcer—Doxorubicin—thyroid cancer	0.00176	0.00396	CcSEcCtD
Clonidine—ADRA2A—trachea—thyroid cancer	0.00175	0.0187	CbGeAlD
Clonidine—Erythema—Sorafenib—thyroid cancer	0.00175	0.00394	CcSEcCtD
Clonidine—Hyperaesthesia—Doxorubicin—thyroid cancer	0.00175	0.00393	CcSEcCtD
Clonidine—SLC6A2—head—thyroid cancer	0.00174	0.0185	CbGeAlD
Clonidine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00173	0.0039	CcSEcCtD
Clonidine—Delirium—Epirubicin—thyroid cancer	0.00172	0.00387	CcSEcCtD
Clonidine—Muscle spasms—Sorafenib—thyroid cancer	0.00168	0.00379	CcSEcCtD
Clonidine—Abdominal pain—Vandetanib—thyroid cancer	0.00168	0.00377	CcSEcCtD
Clonidine—Body temperature increased—Vandetanib—thyroid cancer	0.00168	0.00377	CcSEcCtD
Clonidine—SLC22A5—thyroid gland—thyroid cancer	0.00166	0.0177	CbGeAlD
Clonidine—ADRA1A—head—thyroid cancer	0.00162	0.0172	CbGeAlD
Clonidine—Angioedema—Sorafenib—thyroid cancer	0.0016	0.0036	CcSEcCtD
Clonidine—Nocturia—Epirubicin—thyroid cancer	0.0016	0.00359	CcSEcCtD
Clonidine—Delirium—Doxorubicin—thyroid cancer	0.00159	0.00358	CcSEcCtD
Clonidine—Syncope—Sorafenib—thyroid cancer	0.00157	0.00353	CcSEcCtD
Clonidine—SLC22A4—lymph node—thyroid cancer	0.00156	0.0166	CbGeAlD
Clonidine—ADRA2C—head—thyroid cancer	0.00154	0.0164	CbGeAlD
Clonidine—Loss of consciousness—Sorafenib—thyroid cancer	0.00154	0.00346	CcSEcCtD
Clonidine—Cough—Sorafenib—thyroid cancer	0.00153	0.00344	CcSEcCtD
Clonidine—Atrioventricular block—Epirubicin—thyroid cancer	0.00153	0.00343	CcSEcCtD
Clonidine—Asthenia—Vandetanib—thyroid cancer	0.00152	0.00342	CcSEcCtD
Clonidine—CYP1A2—thyroid gland—thyroid cancer	0.00151	0.0161	CbGeAlD
Clonidine—Pruritus—Vandetanib—thyroid cancer	0.0015	0.00337	CcSEcCtD
Clonidine—Arthralgia—Sorafenib—thyroid cancer	0.00149	0.00335	CcSEcCtD
Clonidine—CYP1A1—thyroid gland—thyroid cancer	0.00149	0.0158	CbGeAlD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00148	0.00333	CcSEcCtD
Clonidine—Nocturia—Doxorubicin—thyroid cancer	0.00148	0.00332	CcSEcCtD
Clonidine—Dermatitis contact—Epirubicin—thyroid cancer	0.00146	0.00329	CcSEcCtD
Clonidine—Abnormal dreams—Epirubicin—thyroid cancer	0.00146	0.00329	CcSEcCtD
Clonidine—Dry mouth—Sorafenib—thyroid cancer	0.00146	0.00328	CcSEcCtD
Clonidine—Diarrhoea—Vandetanib—thyroid cancer	0.00145	0.00326	CcSEcCtD
Clonidine—Influenza like illness—Epirubicin—thyroid cancer	0.00144	0.00323	CcSEcCtD
Clonidine—SLC22A3—lymph node—thyroid cancer	0.00142	0.0151	CbGeAlD
Clonidine—Infection—Sorafenib—thyroid cancer	0.00142	0.00319	CcSEcCtD
Clonidine—Atrioventricular block—Doxorubicin—thyroid cancer	0.00141	0.00318	CcSEcCtD
Clonidine—Shock—Sorafenib—thyroid cancer	0.00141	0.00316	CcSEcCtD
Clonidine—Nervous system disorder—Sorafenib—thyroid cancer	0.0014	0.00315	CcSEcCtD
Clonidine—Dizziness—Vandetanib—thyroid cancer	0.0014	0.00315	CcSEcCtD
Clonidine—Thrombocytopenia—Sorafenib—thyroid cancer	0.0014	0.00315	CcSEcCtD
Clonidine—Skin disorder—Sorafenib—thyroid cancer	0.00139	0.00312	CcSEcCtD
Clonidine—ADRA2A—thyroid gland—thyroid cancer	0.00139	0.0148	CbGeAlD
Clonidine—Dry eye—Epirubicin—thyroid cancer	0.00137	0.00308	CcSEcCtD
Clonidine—Anorexia—Sorafenib—thyroid cancer	0.00136	0.00307	CcSEcCtD
Clonidine—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00136	0.00306	CcSEcCtD
Clonidine—Abnormal dreams—Doxorubicin—thyroid cancer	0.00135	0.00305	CcSEcCtD
Clonidine—Dermatitis contact—Doxorubicin—thyroid cancer	0.00135	0.00305	CcSEcCtD
Clonidine—Vomiting—Vandetanib—thyroid cancer	0.00135	0.00303	CcSEcCtD
Clonidine—Rash maculo-papular—Epirubicin—thyroid cancer	0.00135	0.00303	CcSEcCtD
Clonidine—Rash—Vandetanib—thyroid cancer	0.00134	0.00301	CcSEcCtD
Clonidine—Dermatitis—Vandetanib—thyroid cancer	0.00133	0.003	CcSEcCtD
Clonidine—Influenza like illness—Doxorubicin—thyroid cancer	0.00133	0.00299	CcSEcCtD
Clonidine—Headache—Vandetanib—thyroid cancer	0.00133	0.00299	CcSEcCtD
Clonidine—CYP1A1—head—thyroid cancer	0.00132	0.0141	CbGeAlD
Clonidine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0013	0.00293	CcSEcCtD
Clonidine—Dyspnoea—Sorafenib—thyroid cancer	0.00127	0.00287	CcSEcCtD
Clonidine—Dry eye—Doxorubicin—thyroid cancer	0.00127	0.00285	CcSEcCtD
Clonidine—Nausea—Vandetanib—thyroid cancer	0.00126	0.00283	CcSEcCtD
Clonidine—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.00126	0.00283	CcSEcCtD
Clonidine—Rash maculo-papular—Doxorubicin—thyroid cancer	0.00125	0.0028	CcSEcCtD
Clonidine—Decreased appetite—Sorafenib—thyroid cancer	0.00124	0.0028	CcSEcCtD
Clonidine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00123	0.00278	CcSEcCtD
Clonidine—Fatigue—Sorafenib—thyroid cancer	0.00123	0.00277	CcSEcCtD
Clonidine—ADRA2A—head—thyroid cancer	0.00123	0.0131	CbGeAlD
Clonidine—Pain—Sorafenib—thyroid cancer	0.00122	0.00275	CcSEcCtD
Clonidine—Constipation—Sorafenib—thyroid cancer	0.00122	0.00275	CcSEcCtD
Clonidine—SLC6A2—lymph node—thyroid cancer	0.00122	0.013	CbGeAlD
Clonidine—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00119	0.00267	CcSEcCtD
Clonidine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00117	0.00263	CcSEcCtD
Clonidine—Urticaria—Sorafenib—thyroid cancer	0.00114	0.00255	CcSEcCtD
Clonidine—Abdominal pain—Sorafenib—thyroid cancer	0.00113	0.00254	CcSEcCtD
Clonidine—Body temperature increased—Sorafenib—thyroid cancer	0.00113	0.00254	CcSEcCtD
Clonidine—Cerebrovascular accident—Epirubicin—thyroid cancer	0.0011	0.00247	CcSEcCtD
Clonidine—Lethargy—Epirubicin—thyroid cancer	0.0011	0.00247	CcSEcCtD
Clonidine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.0011	0.00247	CcSEcCtD
Clonidine—ADRA2C—lymph node—thyroid cancer	0.00108	0.0115	CbGeAlD
Clonidine—Pain in extremity—Epirubicin—thyroid cancer	0.00107	0.00242	CcSEcCtD
Clonidine—Hypersensitivity—Sorafenib—thyroid cancer	0.00105	0.00237	CcSEcCtD
Clonidine—SLC22A5—lymph node—thyroid cancer	0.00103	0.011	CbGeAlD
Clonidine—Asthenia—Sorafenib—thyroid cancer	0.00103	0.00231	CcSEcCtD
Clonidine—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00101	0.00228	CcSEcCtD
Clonidine—Lethargy—Doxorubicin—thyroid cancer	0.00101	0.00228	CcSEcCtD
Clonidine—Pruritus—Sorafenib—thyroid cancer	0.00101	0.00227	CcSEcCtD
Clonidine—Pain in extremity—Doxorubicin—thyroid cancer	0.000995	0.00224	CcSEcCtD
Clonidine—Liver function test abnormal—Epirubicin—thyroid cancer	0.000992	0.00223	CcSEcCtD
Clonidine—Abdominal pain upper—Epirubicin—thyroid cancer	0.000982	0.00221	CcSEcCtD
Clonidine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000982	0.00221	CcSEcCtD
Clonidine—Diarrhoea—Sorafenib—thyroid cancer	0.000978	0.0022	CcSEcCtD
Clonidine—ABCB1—trachea—thyroid cancer	0.000976	0.0104	CbGeAlD
Clonidine—Breast disorder—Epirubicin—thyroid cancer	0.000971	0.00218	CcSEcCtD
Clonidine—Nasopharyngitis—Epirubicin—thyroid cancer	0.000961	0.00216	CcSEcCtD
Clonidine—CYP2D6—head—thyroid cancer	0.000952	0.0101	CbGeAlD
Clonidine—Dizziness—Sorafenib—thyroid cancer	0.000945	0.00213	CcSEcCtD
Clonidine—Asthma—Epirubicin—thyroid cancer	0.000929	0.00209	CcSEcCtD
Clonidine—CYP1A1—lymph node—thyroid cancer	0.000923	0.00984	CbGeAlD
Clonidine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000918	0.00207	CcSEcCtD
Clonidine—Vomiting—Sorafenib—thyroid cancer	0.000909	0.00204	CcSEcCtD
Clonidine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000908	0.00204	CcSEcCtD
Clonidine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000908	0.00204	CcSEcCtD
Clonidine—Rash—Sorafenib—thyroid cancer	0.000901	0.00203	CcSEcCtD
Clonidine—Dermatitis—Sorafenib—thyroid cancer	0.0009	0.00203	CcSEcCtD
Clonidine—Breast disorder—Doxorubicin—thyroid cancer	0.000899	0.00202	CcSEcCtD
Clonidine—Headache—Sorafenib—thyroid cancer	0.000896	0.00201	CcSEcCtD
Clonidine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000889	0.002	CcSEcCtD
Clonidine—Dysuria—Epirubicin—thyroid cancer	0.000869	0.00195	CcSEcCtD
Clonidine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000863	0.00194	CcSEcCtD
Clonidine—ADRA2A—lymph node—thyroid cancer	0.000861	0.00917	CbGeAlD
Clonidine—Asthma—Doxorubicin—thyroid cancer	0.00086	0.00193	CcSEcCtD
Clonidine—Pollakiuria—Epirubicin—thyroid cancer	0.000858	0.00193	CcSEcCtD
Clonidine—Nausea—Sorafenib—thyroid cancer	0.000849	0.00191	CcSEcCtD
Clonidine—Weight increased—Epirubicin—thyroid cancer	0.000845	0.0019	CcSEcCtD
Clonidine—Drowsiness—Epirubicin—thyroid cancer	0.000828	0.00186	CcSEcCtD
Clonidine—Urinary tract infection—Epirubicin—thyroid cancer	0.000805	0.00181	CcSEcCtD
Clonidine—Dysuria—Doxorubicin—thyroid cancer	0.000804	0.00181	CcSEcCtD
Clonidine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000799	0.0018	CcSEcCtD
Clonidine—Sweating—Epirubicin—thyroid cancer	0.000794	0.00179	CcSEcCtD
Clonidine—Pollakiuria—Doxorubicin—thyroid cancer	0.000794	0.00179	CcSEcCtD
Clonidine—Weight increased—Doxorubicin—thyroid cancer	0.000782	0.00176	CcSEcCtD
Clonidine—Epistaxis—Epirubicin—thyroid cancer	0.000781	0.00176	CcSEcCtD
Clonidine—ABCB1—thyroid gland—thyroid cancer	0.000772	0.00823	CbGeAlD
Clonidine—Drowsiness—Doxorubicin—thyroid cancer	0.000766	0.00172	CcSEcCtD
Clonidine—Bradycardia—Epirubicin—thyroid cancer	0.000757	0.0017	CcSEcCtD
Clonidine—Rhinitis—Epirubicin—thyroid cancer	0.000745	0.00168	CcSEcCtD
Clonidine—Urinary tract infection—Doxorubicin—thyroid cancer	0.000745	0.00168	CcSEcCtD
Clonidine—Hepatitis—Epirubicin—thyroid cancer	0.000744	0.00167	CcSEcCtD
Clonidine—Hypoaesthesia—Epirubicin—thyroid cancer	0.00074	0.00166	CcSEcCtD
Clonidine—Sweating—Doxorubicin—thyroid cancer	0.000735	0.00165	CcSEcCtD
Clonidine—Epistaxis—Doxorubicin—thyroid cancer	0.000723	0.00163	CcSEcCtD
Clonidine—Bradycardia—Doxorubicin—thyroid cancer	0.0007	0.00158	CcSEcCtD
Clonidine—Eye disorder—Epirubicin—thyroid cancer	0.000695	0.00156	CcSEcCtD
Clonidine—Tinnitus—Epirubicin—thyroid cancer	0.000693	0.00156	CcSEcCtD
Clonidine—Cardiac disorder—Epirubicin—thyroid cancer	0.00069	0.00155	CcSEcCtD
Clonidine—Rhinitis—Doxorubicin—thyroid cancer	0.00069	0.00155	CcSEcCtD
Clonidine—Hepatitis—Doxorubicin—thyroid cancer	0.000688	0.00155	CcSEcCtD
Clonidine—ABCB1—head—thyroid cancer	0.000685	0.0073	CbGeAlD
Clonidine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000685	0.00154	CcSEcCtD
Clonidine—Angiopathy—Epirubicin—thyroid cancer	0.000675	0.00152	CcSEcCtD
Clonidine—Mediastinal disorder—Epirubicin—thyroid cancer	0.00067	0.00151	CcSEcCtD
Clonidine—Arrhythmia—Epirubicin—thyroid cancer	0.000664	0.00149	CcSEcCtD
Clonidine—Alopecia—Epirubicin—thyroid cancer	0.000657	0.00148	CcSEcCtD
Clonidine—Mental disorder—Epirubicin—thyroid cancer	0.000651	0.00147	CcSEcCtD
Clonidine—Erythema—Epirubicin—thyroid cancer	0.000647	0.00146	CcSEcCtD
Clonidine—Eye disorder—Doxorubicin—thyroid cancer	0.000643	0.00145	CcSEcCtD
Clonidine—Tinnitus—Doxorubicin—thyroid cancer	0.000641	0.00144	CcSEcCtD
Clonidine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000639	0.00144	CcSEcCtD
Clonidine—Tension—Epirubicin—thyroid cancer	0.000635	0.00143	CcSEcCtD
Clonidine—Nervousness—Epirubicin—thyroid cancer	0.000629	0.00141	CcSEcCtD
Clonidine—Angiopathy—Doxorubicin—thyroid cancer	0.000624	0.0014	CcSEcCtD
Clonidine—Muscle spasms—Epirubicin—thyroid cancer	0.000622	0.0014	CcSEcCtD
Clonidine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00062	0.00139	CcSEcCtD
Clonidine—Arrhythmia—Doxorubicin—thyroid cancer	0.000615	0.00138	CcSEcCtD
Clonidine—Vision blurred—Epirubicin—thyroid cancer	0.00061	0.00137	CcSEcCtD
Clonidine—Alopecia—Doxorubicin—thyroid cancer	0.000608	0.00137	CcSEcCtD
Clonidine—Mental disorder—Doxorubicin—thyroid cancer	0.000603	0.00136	CcSEcCtD
Clonidine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000601	0.00135	CcSEcCtD
Clonidine—Erythema—Doxorubicin—thyroid cancer	0.000599	0.00135	CcSEcCtD
Clonidine—Agitation—Epirubicin—thyroid cancer	0.000595	0.00134	CcSEcCtD
Clonidine—Tension—Doxorubicin—thyroid cancer	0.000588	0.00132	CcSEcCtD
Clonidine—Malaise—Epirubicin—thyroid cancer	0.000584	0.00131	CcSEcCtD
Clonidine—Nervousness—Doxorubicin—thyroid cancer	0.000582	0.00131	CcSEcCtD
Clonidine—Syncope—Epirubicin—thyroid cancer	0.00058	0.00131	CcSEcCtD
Clonidine—Muscle spasms—Doxorubicin—thyroid cancer	0.000576	0.0013	CcSEcCtD
Clonidine—Palpitations—Epirubicin—thyroid cancer	0.000572	0.00129	CcSEcCtD
Clonidine—Loss of consciousness—Epirubicin—thyroid cancer	0.000569	0.00128	CcSEcCtD
Clonidine—Cough—Epirubicin—thyroid cancer	0.000565	0.00127	CcSEcCtD
Clonidine—Vision blurred—Doxorubicin—thyroid cancer	0.000564	0.00127	CcSEcCtD
Clonidine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000556	0.00125	CcSEcCtD
Clonidine—Chest pain—Epirubicin—thyroid cancer	0.000551	0.00124	CcSEcCtD
Clonidine—Arthralgia—Epirubicin—thyroid cancer	0.000551	0.00124	CcSEcCtD
Clonidine—Agitation—Doxorubicin—thyroid cancer	0.00055	0.00124	CcSEcCtD
Clonidine—Anxiety—Epirubicin—thyroid cancer	0.000549	0.00124	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000547	0.00123	CcSEcCtD
Clonidine—Discomfort—Epirubicin—thyroid cancer	0.000544	0.00122	CcSEcCtD
Clonidine—Malaise—Doxorubicin—thyroid cancer	0.00054	0.00121	CcSEcCtD
Clonidine—Dry mouth—Epirubicin—thyroid cancer	0.000539	0.00121	CcSEcCtD
Clonidine—Syncope—Doxorubicin—thyroid cancer	0.000537	0.00121	CcSEcCtD
Clonidine—Confusional state—Epirubicin—thyroid cancer	0.000533	0.0012	CcSEcCtD
Clonidine—Palpitations—Doxorubicin—thyroid cancer	0.000529	0.00119	CcSEcCtD
Clonidine—Oedema—Epirubicin—thyroid cancer	0.000528	0.00119	CcSEcCtD
Clonidine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000526	0.00118	CcSEcCtD
Clonidine—Infection—Epirubicin—thyroid cancer	0.000525	0.00118	CcSEcCtD
Clonidine—Cough—Doxorubicin—thyroid cancer	0.000523	0.00118	CcSEcCtD
Clonidine—Shock—Epirubicin—thyroid cancer	0.00052	0.00117	CcSEcCtD
Clonidine—Nervous system disorder—Epirubicin—thyroid cancer	0.000518	0.00117	CcSEcCtD
Clonidine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000517	0.00116	CcSEcCtD
Clonidine—Tachycardia—Epirubicin—thyroid cancer	0.000516	0.00116	CcSEcCtD
Clonidine—Skin disorder—Epirubicin—thyroid cancer	0.000513	0.00115	CcSEcCtD
Clonidine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000511	0.00115	CcSEcCtD
Clonidine—Arthralgia—Doxorubicin—thyroid cancer	0.00051	0.00115	CcSEcCtD
Clonidine—Chest pain—Doxorubicin—thyroid cancer	0.00051	0.00115	CcSEcCtD
Clonidine—Anxiety—Doxorubicin—thyroid cancer	0.000508	0.00114	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000506	0.00114	CcSEcCtD
Clonidine—Discomfort—Doxorubicin—thyroid cancer	0.000504	0.00113	CcSEcCtD
Clonidine—Anorexia—Epirubicin—thyroid cancer	0.000504	0.00113	CcSEcCtD
Clonidine—Dry mouth—Doxorubicin—thyroid cancer	0.000499	0.00112	CcSEcCtD
Clonidine—Hypotension—Epirubicin—thyroid cancer	0.000494	0.00111	CcSEcCtD
Clonidine—Confusional state—Doxorubicin—thyroid cancer	0.000493	0.00111	CcSEcCtD
Clonidine—Oedema—Doxorubicin—thyroid cancer	0.000489	0.0011	CcSEcCtD
Clonidine—Infection—Doxorubicin—thyroid cancer	0.000486	0.00109	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000481	0.00108	CcSEcCtD
Clonidine—Shock—Doxorubicin—thyroid cancer	0.000481	0.00108	CcSEcCtD
Clonidine—ABCB1—lymph node—thyroid cancer	0.00048	0.00511	CbGeAlD
Clonidine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000479	0.00108	CcSEcCtD
Clonidine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000479	0.00108	CcSEcCtD
Clonidine—Insomnia—Epirubicin—thyroid cancer	0.000478	0.00107	CcSEcCtD
Clonidine—Tachycardia—Doxorubicin—thyroid cancer	0.000477	0.00107	CcSEcCtD
Clonidine—Skin disorder—Doxorubicin—thyroid cancer	0.000475	0.00107	CcSEcCtD
Clonidine—Paraesthesia—Epirubicin—thyroid cancer	0.000474	0.00107	CcSEcCtD
Clonidine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000473	0.00106	CcSEcCtD
Clonidine—Dyspnoea—Epirubicin—thyroid cancer	0.000471	0.00106	CcSEcCtD
Clonidine—Somnolence—Epirubicin—thyroid cancer	0.00047	0.00106	CcSEcCtD
Clonidine—Anorexia—Doxorubicin—thyroid cancer	0.000466	0.00105	CcSEcCtD
Clonidine—Decreased appetite—Epirubicin—thyroid cancer	0.000459	0.00103	CcSEcCtD
Clonidine—Hypotension—Doxorubicin—thyroid cancer	0.000457	0.00103	CcSEcCtD
Clonidine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000456	0.00103	CcSEcCtD
Clonidine—Fatigue—Epirubicin—thyroid cancer	0.000455	0.00102	CcSEcCtD
Clonidine—Constipation—Epirubicin—thyroid cancer	0.000452	0.00102	CcSEcCtD
Clonidine—Pain—Epirubicin—thyroid cancer	0.000452	0.00102	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000445	0.001	CcSEcCtD
Clonidine—Insomnia—Doxorubicin—thyroid cancer	0.000442	0.000995	CcSEcCtD
Clonidine—Paraesthesia—Doxorubicin—thyroid cancer	0.000439	0.000987	CcSEcCtD
Clonidine—Dyspnoea—Doxorubicin—thyroid cancer	0.000436	0.00098	CcSEcCtD
Clonidine—Feeling abnormal—Epirubicin—thyroid cancer	0.000435	0.000979	CcSEcCtD
Clonidine—Somnolence—Doxorubicin—thyroid cancer	0.000435	0.000978	CcSEcCtD
Clonidine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000432	0.000972	CcSEcCtD
Clonidine—Decreased appetite—Doxorubicin—thyroid cancer	0.000425	0.000956	CcSEcCtD
Clonidine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000422	0.000949	CcSEcCtD
Clonidine—Fatigue—Doxorubicin—thyroid cancer	0.000421	0.000948	CcSEcCtD
Clonidine—Urticaria—Epirubicin—thyroid cancer	0.00042	0.000944	CcSEcCtD
Clonidine—Constipation—Doxorubicin—thyroid cancer	0.000418	0.00094	CcSEcCtD
Clonidine—Pain—Doxorubicin—thyroid cancer	0.000418	0.00094	CcSEcCtD
Clonidine—Abdominal pain—Epirubicin—thyroid cancer	0.000418	0.000939	CcSEcCtD
Clonidine—Body temperature increased—Epirubicin—thyroid cancer	0.000418	0.000939	CcSEcCtD
Clonidine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000403	0.000906	CcSEcCtD
Clonidine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.0004	0.000899	CcSEcCtD
Clonidine—Hypersensitivity—Epirubicin—thyroid cancer	0.000389	0.000876	CcSEcCtD
Clonidine—Urticaria—Doxorubicin—thyroid cancer	0.000388	0.000874	CcSEcCtD
Clonidine—Abdominal pain—Doxorubicin—thyroid cancer	0.000386	0.000869	CcSEcCtD
Clonidine—Body temperature increased—Doxorubicin—thyroid cancer	0.000386	0.000869	CcSEcCtD
Clonidine—Asthenia—Epirubicin—thyroid cancer	0.000379	0.000853	CcSEcCtD
Clonidine—Pruritus—Epirubicin—thyroid cancer	0.000374	0.000841	CcSEcCtD
Clonidine—Diarrhoea—Epirubicin—thyroid cancer	0.000361	0.000813	CcSEcCtD
Clonidine—Hypersensitivity—Doxorubicin—thyroid cancer	0.00036	0.00081	CcSEcCtD
Clonidine—Asthenia—Doxorubicin—thyroid cancer	0.000351	0.000789	CcSEcCtD
Clonidine—Dizziness—Epirubicin—thyroid cancer	0.000349	0.000786	CcSEcCtD
Clonidine—Pruritus—Doxorubicin—thyroid cancer	0.000346	0.000778	CcSEcCtD
Clonidine—Vomiting—Epirubicin—thyroid cancer	0.000336	0.000756	CcSEcCtD
Clonidine—Diarrhoea—Doxorubicin—thyroid cancer	0.000334	0.000752	CcSEcCtD
Clonidine—Rash—Epirubicin—thyroid cancer	0.000333	0.000749	CcSEcCtD
Clonidine—Dermatitis—Epirubicin—thyroid cancer	0.000333	0.000749	CcSEcCtD
Clonidine—Headache—Epirubicin—thyroid cancer	0.000331	0.000744	CcSEcCtD
Clonidine—Dizziness—Doxorubicin—thyroid cancer	0.000323	0.000727	CcSEcCtD
Clonidine—Nausea—Epirubicin—thyroid cancer	0.000314	0.000706	CcSEcCtD
Clonidine—Vomiting—Doxorubicin—thyroid cancer	0.000311	0.000699	CcSEcCtD
Clonidine—Rash—Doxorubicin—thyroid cancer	0.000308	0.000693	CcSEcCtD
Clonidine—Dermatitis—Doxorubicin—thyroid cancer	0.000308	0.000693	CcSEcCtD
Clonidine—Headache—Doxorubicin—thyroid cancer	0.000306	0.000689	CcSEcCtD
Clonidine—Nausea—Doxorubicin—thyroid cancer	0.00029	0.000653	CcSEcCtD
Clonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	3.24e-05	0.000811	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—SST—thyroid cancer	3.24e-05	0.00081	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	3.2e-05	0.0008	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PRKAR1A—thyroid cancer	3.19e-05	0.000798	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—CALCA—thyroid cancer	3.12e-05	0.00078	CbGpPWpGaD
Clonidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	3.1e-05	0.000776	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	3.09e-05	0.000773	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PTCH1—thyroid cancer	3.06e-05	0.000764	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MEN1—thyroid cancer	3.05e-05	0.000763	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—CDK1—thyroid cancer	3.04e-05	0.00076	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TSHR—thyroid cancer	3.03e-05	0.000758	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TSHR—thyroid cancer	2.98e-05	0.000746	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.98e-05	0.000746	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PRKAR1A—thyroid cancer	2.98e-05	0.000745	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—TPR—thyroid cancer	2.95e-05	0.000736	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PRKAR1A—thyroid cancer	2.94e-05	0.000734	CbGpPWpGaD
Clonidine—ADRA2B—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.92e-05	0.000729	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PRKAR1A—thyroid cancer	2.9e-05	0.000724	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.88e-05	0.00072	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MEN1—thyroid cancer	2.85e-05	0.000712	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—HPGD—thyroid cancer	2.83e-05	0.000707	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—CDK1—thyroid cancer	2.83e-05	0.000706	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MEN1—thyroid cancer	2.81e-05	0.000701	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—SST—thyroid cancer	2.8e-05	0.000699	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PTCH1—thyroid cancer	2.76e-05	0.00069	CbGpPWpGaD
Clonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	2.76e-05	0.000689	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.74e-05	0.000683	CbGpPWpGaD
Clonidine—ADRA2C—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.72e-05	0.000681	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—SLC5A5—thyroid cancer	2.71e-05	0.000678	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CHST14—thyroid cancer	2.71e-05	0.000677	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—TPR—thyroid cancer	2.7e-05	0.000674	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CALCA—thyroid cancer	2.69e-05	0.000673	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	2.66e-05	0.000664	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TSHR—thyroid cancer	2.65e-05	0.000662	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PRKAR1A—thyroid cancer	2.61e-05	0.000652	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—SLC5A5—thyroid cancer	2.6e-05	0.00065	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PTCH1—thyroid cancer	2.58e-05	0.000644	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—TPR—thyroid cancer	2.55e-05	0.000637	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PTCH1—thyroid cancer	2.54e-05	0.000634	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SST—thyroid cancer	2.52e-05	0.000631	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	2.51e-05	0.000627	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MEN1—thyroid cancer	2.49e-05	0.000623	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TSHR—thyroid cancer	2.46e-05	0.000615	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—HRAS—thyroid cancer	2.45e-05	0.000613	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CDK1—thyroid cancer	2.44e-05	0.000609	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CALCA—thyroid cancer	2.43e-05	0.000607	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PRKAR1A—thyroid cancer	2.42e-05	0.000605	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—PPARG—thyroid cancer	2.36e-05	0.00059	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SST—thyroid cancer	2.36e-05	0.000589	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—NRAS—thyroid cancer	2.33e-05	0.000582	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SST—thyroid cancer	2.32e-05	0.00058	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MEN1—thyroid cancer	2.32e-05	0.000579	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.3e-05	0.000574	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.29e-05	0.000573	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—RXRA—thyroid cancer	2.28e-05	0.00057	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.27e-05	0.000568	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CALCA—thyroid cancer	2.27e-05	0.000567	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PTCH1—thyroid cancer	2.25e-05	0.000563	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CALCA—thyroid cancer	2.23e-05	0.000558	CbGpPWpGaD
Clonidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.21e-05	0.000553	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—SLC5A5—thyroid cancer	2.2e-05	0.000551	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CDK1—thyroid cancer	2.2e-05	0.00055	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—RXRA—thyroid cancer	2.19e-05	0.000546	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HPGD—thyroid cancer	2.18e-05	0.000546	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—NRAS—thyroid cancer	2.17e-05	0.000543	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PTCH1—thyroid cancer	2.09e-05	0.000523	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SST—thyroid cancer	2.06e-05	0.000515	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CDK1—thyroid cancer	2.05e-05	0.000513	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—TPR—thyroid cancer	2.04e-05	0.000509	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.04e-05	0.000509	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CDK1—thyroid cancer	2.02e-05	0.000505	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—SLC5A5—thyroid cancer	2.02e-05	0.000505	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2e-05	0.000501	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—KRAS—thyroid cancer	2e-05	0.000501	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CALCA—thyroid cancer	1.98e-05	0.000496	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NRG1—thyroid cancer	1.96e-05	0.000489	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—TPR—thyroid cancer	1.92e-05	0.00048	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SST—thyroid cancer	1.92e-05	0.000479	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—SLC5A5—thyroid cancer	1.91e-05	0.000477	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.89e-05	0.000472	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—KRAS—thyroid cancer	1.87e-05	0.000468	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—PTGS2—thyroid cancer	1.86e-05	0.000464	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—RXRA—thyroid cancer	1.85e-05	0.000463	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CALCA—thyroid cancer	1.84e-05	0.000461	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CDK1—thyroid cancer	1.8e-05	0.000449	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.79e-05	0.000447	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—TP53—thyroid cancer	1.78e-05	0.000445	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—NRAS—thyroid cancer	1.77e-05	0.000441	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NRG1—thyroid cancer	1.77e-05	0.000441	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TERT—thyroid cancer	1.76e-05	0.000439	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.72e-05	0.00043	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—HRAS—thyroid cancer	1.7e-05	0.000425	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—RXRA—thyroid cancer	1.7e-05	0.000424	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HIF1A—thyroid cancer	1.68e-05	0.00042	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CDK1—thyroid cancer	1.67e-05	0.000417	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—TP53—thyroid cancer	1.66e-05	0.000416	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NRG1—thyroid cancer	1.65e-05	0.000412	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—TPR—thyroid cancer	1.63e-05	0.000406	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NRG1—thyroid cancer	1.62e-05	0.000406	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—PTEN—thyroid cancer	1.62e-05	0.000405	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—RXRA—thyroid cancer	1.6e-05	0.000401	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.6e-05	0.0004	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—HRAS—thyroid cancer	1.59e-05	0.000397	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TERT—thyroid cancer	1.59e-05	0.000396	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.56e-05	0.00039	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.52e-05	0.000381	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—KRAS—thyroid cancer	1.52e-05	0.00038	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HIF1A—thyroid cancer	1.52e-05	0.000379	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—AKT1—thyroid cancer	1.5e-05	0.000376	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TERT—thyroid cancer	1.48e-05	0.00037	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—NRAS—thyroid cancer	1.48e-05	0.00037	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TERT—thyroid cancer	1.46e-05	0.000364	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.45e-05	0.000362	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NRG1—thyroid cancer	1.44e-05	0.00036	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PPARG—thyroid cancer	1.44e-05	0.00036	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.44e-05	0.000359	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HIF1A—thyroid cancer	1.42e-05	0.000354	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—AKT1—thyroid cancer	1.4e-05	0.000351	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HIF1A—thyroid cancer	1.39e-05	0.000348	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—BRAF—thyroid cancer	1.39e-05	0.000347	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PPARG—thyroid cancer	1.38e-05	0.000345	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—TP53—thyroid cancer	1.35e-05	0.000338	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	1.34e-05	0.000335	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	1.34e-05	0.000334	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TERT—thyroid cancer	1.29e-05	0.000323	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—HRAS—thyroid cancer	1.29e-05	0.000323	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—RXRA—thyroid cancer	1.28e-05	0.00032	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—KRAS—thyroid cancer	1.27e-05	0.000318	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	1.26e-05	0.000314	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—TPR—thyroid cancer	1.25e-05	0.000314	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—NRAS—thyroid cancer	1.25e-05	0.000312	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	1.24e-05	0.000309	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.23e-05	0.000308	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—NRAS—thyroid cancer	1.23e-05	0.000307	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.22e-05	0.000304	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—RXRA—thyroid cancer	1.21e-05	0.000302	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TERT—thyroid cancer	1.2e-05	0.000301	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—BRAF—thyroid cancer	1.17e-05	0.000293	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PPARG—thyroid cancer	1.17e-05	0.000292	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	1.15e-05	0.000288	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	1.15e-05	0.000287	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	1.15e-05	0.000287	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—AKT1—thyroid cancer	1.14e-05	0.000285	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.14e-05	0.000285	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PTGS2—thyroid cancer	1.13e-05	0.000283	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	1.09e-05	0.000273	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTGS2—thyroid cancer	1.09e-05	0.000271	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—HRAS—thyroid cancer	1.08e-05	0.00027	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	1.07e-05	0.000268	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PPARG—thyroid cancer	1.07e-05	0.000268	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	1.06e-05	0.000264	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—AKT1—thyroid cancer	1.05e-05	0.000263	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	1.03e-05	0.000256	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—RXRA—thyroid cancer	1.02e-05	0.000256	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CCND1—thyroid cancer	1.01e-05	0.000254	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	1.01e-05	0.000253	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PPARG—thyroid cancer	1.01e-05	0.000253	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.95e-06	0.000249	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PTEN—thyroid cancer	9.88e-06	0.000247	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PTEN—thyroid cancer	9.8e-06	0.000245	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	9.77e-06	0.000244	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—AKT1—thyroid cancer	9.56e-06	0.000239	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	9.53e-06	0.000238	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	9.5e-06	0.000237	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTEN—thyroid cancer	9.47e-06	0.000237	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	9.39e-06	0.000235	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	9.39e-06	0.000235	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—AKT1—thyroid cancer	9.33e-06	0.000233	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTGS2—thyroid cancer	9.2e-06	0.00023	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	9.16e-06	0.000229	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	9.13e-06	0.000228	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	8.98e-06	0.000224	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	8.87e-06	0.000222	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	8.84e-06	0.000221	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NRAS—thyroid cancer	8.74e-06	0.000218	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	8.73e-06	0.000218	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	8.72e-06	0.000218	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	8.63e-06	0.000216	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	8.56e-06	0.000214	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTGS2—thyroid cancer	8.43e-06	0.000211	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	8.42e-06	0.00021	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	8.26e-06	0.000206	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	8.13e-06	0.000203	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PPARG—thyroid cancer	8.09e-06	0.000202	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	8.06e-06	0.000201	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTEN—thyroid cancer	8.02e-06	0.000201	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	7.98e-06	0.000199	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTGS2—thyroid cancer	7.97e-06	0.000199	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	7.93e-06	0.000198	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—RXRA—thyroid cancer	7.89e-06	0.000197	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	7.89e-06	0.000197	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	7.76e-06	0.000194	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PPARG—thyroid cancer	7.62e-06	0.00019	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KRAS—thyroid cancer	7.52e-06	0.000188	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	7.48e-06	0.000187	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	7.41e-06	0.000185	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	7.37e-06	0.000184	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTEN—thyroid cancer	7.35e-06	0.000184	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	7.25e-06	0.000181	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	7.22e-06	0.00018	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	7.21e-06	0.00018	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	7.05e-06	0.000176	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	6.95e-06	0.000174	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTEN—thyroid cancer	6.95e-06	0.000174	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	6.79e-06	0.00017	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	6.71e-06	0.000168	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—thyroid cancer	6.69e-06	0.000167	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	6.55e-06	0.000164	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPARG—thyroid cancer	6.46e-06	0.000161	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	6.44e-06	0.000161	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HRAS—thyroid cancer	6.39e-06	0.00016	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTGS2—thyroid cancer	6.36e-06	0.000159	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	6.34e-06	0.000159	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	6.24e-06	0.000156	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—thyroid cancer	6.04e-06	0.000151	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTGS2—thyroid cancer	6e-06	0.00015	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	5.99e-06	0.00015	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	5.77e-06	0.000144	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—AKT1—thyroid cancer	5.69e-06	0.000142	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKT1—thyroid cancer	5.65e-06	0.000141	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—thyroid cancer	5.64e-06	0.000141	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTEN—thyroid cancer	5.55e-06	0.000139	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—thyroid cancer	5.55e-06	0.000139	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	5.55e-06	0.000139	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—AKT1—thyroid cancer	5.46e-06	0.000136	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	5.39e-06	0.000135	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	5.31e-06	0.000133	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTEN—thyroid cancer	5.23e-06	0.000131	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	5.15e-06	0.000129	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	5.1e-06	0.000127	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTGS2—thyroid cancer	5.08e-06	0.000127	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPARG—thyroid cancer	4.98e-06	0.000125	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—thyroid cancer	4.93e-06	0.000123	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	4.76e-06	0.000119	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	4.71e-06	0.000118	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	4.69e-06	0.000117	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—AKT1—thyroid cancer	4.62e-06	0.000116	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—thyroid cancer	4.58e-06	0.000114	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTEN—thyroid cancer	4.43e-06	0.000111	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	4.38e-06	0.000109	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—AKT1—thyroid cancer	4.24e-06	0.000106	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	4.16e-06	0.000104	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—AKT1—thyroid cancer	4e-06	0.0001	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.92e-06	9.8e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	3.87e-06	9.66e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTEN—thyroid cancer	3.42e-06	8.54e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AKT1—thyroid cancer	3.2e-06	7.99e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKT1—thyroid cancer	3.01e-06	7.53e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKT1—thyroid cancer	2.55e-06	6.38e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKT1—thyroid cancer	1.97e-06	4.92e-05	CbGpPWpGaD
